XML 39 R28.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity (Tables)
9 Months Ended
Mar. 31, 2022
Stockholders' Equity  
Schedule of stock-based compensation expense in the consolidated statements of operations

We recorded stock-based compensation expense in the consolidated statements of operations as follows (in thousands):

Three Months Ended March 31, 

    

Nine Months Ended March 31, 

    

2021

    

2022

    

2021

    

2022

Cost of goods sold

$

199

$

205

$

571

$

616

Selling, general and administrative

7,223

6,567

 

18,391

19,977

Research and development

143

126

 

424

393

Stock-based compensation expense

$

7,565

$

6,898

$

19,386

$

20,986

Summary of stock option activity

Weighted

Average

Weighted-Average

Aggregate

Number of

Exercise

Remaining Contractual

Intrinsic Value

    

Options

    

Price

    

Term

    

(in thousands)

Outstanding at June 30, 2021

 

255,220

 

$

50.24

 

Granted

 

22,954

96.38

Exercised

 

(164,612)

34.61

Expired or forfeited

 

(834)

71.83

Outstanding at March 31, 2022

 

112,728

82.30

6.4 years

$

816

Exercisable at March 31, 2022

72,371

76.69

 

4.9 years

780

Summary of RSU award activity

Weighted-

Average

    

Shares

    

Fair Value

Nonvested at June 30, 2021

 

435,925

$

84.16

Granted

 

334,435

90.31

Vested

 

(335,099)

82.66

Forfeited

 

(4,542)

84.21

Nonvested at March 31, 2022

 

430,719

$

90.11